Stent Omission May Be Acceptable After Ureteroscopy – Renal and Urology News
There have been no prospective studies comparing stent use vs nonuse after ureteroscopy for uncomplicated renal stones.
Related Articles
FDA issues refusal to file letter on sBLA for nogapendekin alfa inbakicept
The sBLA for NAI was submitted to the FDA in March 2025.
Treatment Decisions in Patients With Low- vs High-Volume Disease
A panelist discusses how these comparative results could influence clinical decision-making by suggesting potentially different magnitudes of benefit between enzalutamide and darolutamide depending on disease…
Holmium:YAG vs Thulium Fiber Laser Similarly Effective for Kidney Stone Management – Renal and Urology News
This is the first randomized trial directly comparing pulse-modulated Holmium:YAG laser and thulium fiber laser treatment of kidney stones during ureteroscopy.
AUA 2025 special: Dr. Neal Shore discusses phase 3 CREST study results – Uroweb
EAU Podcast: At the 2025 American Urological Association Meeting in Las Vegas, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talked to Dr. Neal Shore…
Validation of Prognostic Models for Renal Cell Carcinoma Recurrence, Cancer-Specific Mortality, and All-Cause Mortality | Journal of Urology
Purpose:Postoperative prognostic tools allow for improved prediction of future recurrence risk, patient counseling, assessment of eligibility for adjuvant treatments, and appropriate follow-up surveillance. The purpose…
New Robotic-Assisted Surgery System Shows Promise for Radical Genitourinary Cancer Surgeries – Renal and Urology News
The study findings are the first report of the Hugo™ robotic-assisted surgery system used in the US.
Industry-Sponsored Research Funding to Urologists in the United States Between 2014 and 2022 | Urology Practice
Introduction:Urologists face challenges in obtaining public research funding, leading to increasing reliance on the industry for research support. This study aimed to examine the extent…
Higher Risk Renal Angiomyolipomas: Surveillance Remains a Safe Management Option | Urology Practice
Introduction:This retrospective study furthers our understanding of risk factors associated with hemorrhage and intervention in renal angiomyolipomas (R-AMLs), particularly in larger tumors (≥4 cm) and…
Patient-Prioritized Outcomes Better After Radical Cystectomy vs Bladder Sparing Tx for NMIBC – Renal and Urology News
The CISTO study is the only going prospective study comparing radical cystectomy vs bladder-sparing options for high-grade NMIBC.
Editorial Comment | Journal of Urology
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…